Feasibility of Using NeuraSignal Transcranial Doppler Robot

Part of paid clinical trials in Birmingham, Alabama.

Sponsor
University of Alabama at Birmingham
Study ID
NCT06565442
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Cerebral Autoregulation

Eligibility Criteria

Sex
ALL
Age
18 Years - 89 Years
Healthy Volunteers
Not accepted

Interventions

  • NeuraSignal transcranial doppler robot — DEVICE
    measure cerebral blood flow correlated with arterial blood pressure to generate individualized cerebral autoregulatory curves

Study Details

The purpose of this study is to determine the feasibility of using the NeuraSignal transcranial doppler robot in a neuro ICU setting to measure cerebral blood flow correlated with arterial blood pressure to generate individualized cerebral autoregulatory curves

Key Dates

Start date
Jun 15, 2026
Status verified
Jun 2025
Primary completion
Dec 14, 2026
Completion
Dec 15, 2027

Study Design

Enrollment
20 participants (estimated)

Arms

  • Arm: Study Group
    Using the NeuraSignal transcranial doppler robot in a neuro ICU setting to measure cerebral blood flow correlated with arterial blood pressure to generate individualized cerebral autoregulatory curves.

Primary Outcome Measure

Primary outcome [ Time Frame: one year ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
UAB Department of Anesthesiology and Perioperative MedicineBirminghamAlabama35249
Shanna Graves
[email protected]
205-975-2845

Find similar trials in Birmingham, AL

By research site
UAB Department of Anesthesiology and Perioperative Medicine· Birmingham, AL